Huntsman Ronald Kirk
SEC insider (Form 3/4/5 filer). CIK 0001835498. Chief Executive Officer at Vivos Therapeutics, Inc. (VVOS). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in LITTLETON, CO.
Companies Huntsman Ronald Kirk has filed insider reports for
- Vivos Therapeutics, Inc. (VVOS): Director, Officer, Chief Executive Officer
Huntsman Ronald Kirk
CIK: 0001835498
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VVOS
Vivos Therapeutics, Inc.
DirectorOfficer